BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19484742)

  • 81. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
    Zinatizadeh MR; Miri SR; Zarandi PK; Chalbatani GM; RapĂ´so C; Mirzaei HR; Akbari ME; Mahmoodzadeh H
    Genes Dis; 2021 Jan; 8(1):48-60. PubMed ID: 33569513
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Hippo-YAP signaling pathway in the liver: more than a size gatekeeper!].
    Gilgenkrantz H
    Med Sci (Paris); 2011 May; 27(5):479-81. PubMed ID: 21609667
    [No Abstract]   [Full Text] [Related]  

  • 83. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway.
    Hergovich A
    Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway.
    Poon CL; Lin JI; Zhang X; Harvey KF
    Dev Cell; 2011 Nov; 21(5):896-906. PubMed ID: 22075148
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hippo signaling pathway in lung development, regeneration, and diseases.
    Fu SL; Zhao WY; Zhang WJ; Song H; Ji HB; Tang N
    Yi Chuan; 2017 Jul; 39(7):597-606. PubMed ID: 28757474
    [TBL] [Abstract][Full Text] [Related]  

  • 86. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
    Nguyen HT; Kugler JM; Cohen SM
    PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Hippo pathway and apico-basal cell polarity.
    Genevet A; Tapon N
    Biochem J; 2011 Jun; 436(2):213-24. PubMed ID: 21568941
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases.
    Bao Y; Sumita K; Kudo T; Withanage K; Nakagawa K; Ikeda M; Ohno K; Wang Y; Hata Y
    Genes Cells; 2009 Dec; 14(12):1369-81. PubMed ID: 19919647
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Yorkie and Scalloped: partners in growth activation.
    Bandura JL; Edgar BA
    Dev Cell; 2008 Mar; 14(3):315-6. PubMed ID: 18331708
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway.
    Dutchak K; Garnett S; Nicoll M; de Bruyns A; Dankort D
    Mol Cancer Res; 2022 May; 20(5):770-781. PubMed ID: 35046109
    [TBL] [Abstract][Full Text] [Related]  

  • 92. NDR/LATS-family protein kinase genes are indispensable for embryogenesis in Arabidopsis.
    Yoon HS; Fujino K; Liu S; Takano T; Tsugama D
    FEBS Open Bio; 2021 Sep; 11(9):2600-2606. PubMed ID: 34320276
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Transcription and processing: multilayer controls of RNA biogenesis by the Hippo pathway.
    Yu FX; Guan KL
    EMBO J; 2014 May; 33(9):942-4. PubMed ID: 24639555
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.
    Kastan N; Gnedeva K; Alisch T; Petelski AA; Huggins DJ; Chiaravalli J; Aharanov A; Shakked A; Tzahor E; Nagiel A; Segil N; Hudspeth AJ
    Nat Commun; 2021 May; 12(1):3100. PubMed ID: 34035288
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.
    Gundogdu R; Hergovich A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31185650
    [TBL] [Abstract][Full Text] [Related]  

  • 96. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.
    Guo C; Tommasi S; Liu L; Yee JK; Dammann R; Pfeifer GP
    Curr Biol; 2007 Apr; 17(8):700-5. PubMed ID: 17379520
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.
    Hong AW; Meng Z; Plouffe SW; Lin Z; Zhang M; Guan KL
    Genes Dev; 2020 Apr; 34(7-8):511-525. PubMed ID: 32115406
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Characterization of Hippo Pathway Components by Gene Inactivation.
    Plouffe SW; Meng Z; Lin KC; Lin B; Hong AW; Chun JV; Guan KL
    Mol Cell; 2016 Dec; 64(5):993-1008. PubMed ID: 27912098
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cell cycle regulated interaction of a yeast Hippo kinase and its activator MO25/Hym1.
    Hsu J; Weiss EL
    PLoS One; 2013; 8(10):e78334. PubMed ID: 24205201
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Multi-scale modeling of hippo signaling identifies homeostatic control by YAP-LATS negative feedback.
    Sun T
    Biosystems; 2021 Oct; 208():104475. PubMed ID: 34237349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.